SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Balancing benefits and harms in health care
3 references·8 citing·40 second hop
Balancing benefits and harms in health care (2003)Balancing benefits and harms in health ca…The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials (2001)The CONSORT statement: revise…Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials (2001)Incomplete evidence: the inad…Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement (1999)Improving the quality of repo…Inadequate Reporting of Complications in Randomized Controlled Trials Cited as Supporting Evidence Underpinning AAOS CPG Recommendations for Hip and Knee Osteoarthritis: Application of the CONSORT Harms Checklist (2022)Inadequate Reporting of Compl…Harms-related data are poorly reported among randomized controlled trials underpinning the American Academy of Orthopaedic Surgeons clinical practice guideline recommendations for rotator cuff injuries (2022)Harms-related data are poorly…The reporting of adverse events following spinal manipulation in randomized clinical trials—a systematic review (2016)The reporting of adverse even…Systematic reviews of adverse effects of drug interventions: a survey of their conduct and reporting quality (2009)Systematic reviews of adverse…Assessment of adverse effects and applicability – two areas not (yet) covered adequately in Cochrane reports (2008)Assessment of adverse effects…Room for improvement? A survey of the methods used in systematic reviews of adverse effects (2006)Room for improvement? A surve…How to spot bias and other potential problems in randomised controlled trials (2004)How to spot bias and other po…Assessing harmful effects in systematic Reviews (2004)Assessing harmful effects in …Health Measurement Scales: A Practical Guide to Their Development and Use (1989)Assessing the quality of reports of randomized clinical trials: Is blinding necessary? (1996)Meta-analysis of Observational Studies in Epidemiology A Proposal for Reporting (2000)Core outcome domains for chronic pain clinical trials: IMMPACT recommendations (2003)Improving the Reporting Quality of Nonrandomized Evaluations of Behavioral and Public Health Interventions: The TREND Statement (2004)Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration (2007)The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. (1998)Methodological index for non‐randomized studies ( MINORS ): development and validation of a new instrument (2003)Reporting of adverse events in systematic reviews can be improved: survey results (2008)The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses (2014)Cannabis in the management of PTSD: a systematic review (2021)Cochrane Handbook for Systematic Reviews of Interventions (2008)No consensus exists on search reporting methods for systematic reviews (2008)Harms in Systematic Reviews Paper 1: An introduction to research on harms (2021)Reporting of Adverse Effects in Clinical Trials Should Be Improved (1999)Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. (2001)The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials (2001)Safety Reporting in Randomized Trials of Mental Health Interventions (2004)Poor reporting and inadequate searches were apparent in systematic reviews of adverse effects (2008)Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement (2004)External validity of randomised controlled trials: “To whom do the results of this trial apply?” (2005)Empirical Evidence of Bias (1995)Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials (1995)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials (2001)Evaluating offending behaviour programmes (2008)Bias in experimental nursing research: Strategies to improve the quality and explanatory power of nursing science (2009)Reporting quality of trial abstracts—improved yet suboptimal: A systematic review and meta‐analysis (2018)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)The Cochrane Collaboration's tool for assessing risk of bias in randomised trials (2011)Assignment of adverse event indexing terms in randomized clinical trials involving spinal manipulative therapy: an audit of records in MEDLINE and EMBASE databases (2017)A methodological review revealed that reporting of trials in manual therapy has not improved over time (2020)Reporting of adverse events associated with spinal manipulation in randomised clinical trials: an updated systematic review (2023)Understanding randomised controlled trials (2005)Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane reviewa (2012)Guidelines for reporting meta-epidemiological methodology research (2017)Reporting a program evaluation: Needs, program plan, intervention, and decisions (2013)The Development of a Checklist to Enhance Methodological Quality in Intervention Programs (2016)A new risk of bias checklist applicable to randomized trials, observational studies, and systematic reviews was developed and validated to be used for systematic reviews focusing on drug adverse events (2017)
this work references cited by second hop

References

  • 1999Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement4,828 cited
  • 2001The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials2,754 cited
  • 2001Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials110 cited

Cited by

  • 2004How to spot bias and other potential problems in randomised controlled trials78 cited
  • 2006Room for improvement? A survey of the methods used in systematic reviews of adverse effects73 cited
  • 2004Assessing harmful effects in systematic Reviews69 cited
  • 2009Systematic reviews of adverse effects of drug interventions: a survey of their conduct and reporting quality54 cited
  • 2016The reporting of adverse events following spinal manipulation in randomized clinical trials—a systematic review44 cited
  • 2008Assessment of adverse effects and applicability – two areas not (yet) covered adequately in Cochrane reports19 cited
  • 2022Inadequate Reporting of Complications in Randomized Controlled Trials Cited as Supporting Evidence Underpinning AAOS CPG Recommendations for Hip and Knee Osteoarthritis: Application of the CONSORT Harms Checklist17 cited
  • 2022Harms-related data are poorly reported among randomized controlled trials underpinning the American Academy of Orthopaedic Surgeons clinical practice guideline recommendations for rotator cuff injuries12 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work